Skip to main content

Amgen statistics

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.8B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Amgen is valued at $253.8B on its latest close. Its price is 27.0 times its earnings.

Market value$253.8B
Enterprise value$292.7B
Price / earnings27.03
Price / sales6.52
Price / book17.68
EV / EBITDA17.12
EV / sales7.52
Price / free cash flow26.49
Price / free cash flow, own 5-year average18.47
EV / EBIT23.36
EV / free cash flow30.75
Free cash flow yield3.8%
Dividend yield2.1%

Share price

Latest close$465.67
Day's change−0.3%
52-week high$483.99
52-week low$312.39
From 52-week high−3.8%
Return · 1 month+7.7%
Return · 3 months+7.4%
Return · year to date+42.3%
Return · 1 year+38.5%
Beta · 1 year against the S&P 5000.49
50-day average$425.31
200-day average$381.01
RSI 1461.8
Average volume · 20 sessions2.7M

Margins and returns

For fiscal 2025, as filed.

Gross margin67.2%
Operating margin24.7%
Net margin21.0%
Free cash flow margin22.0%
Return on equity106%
Return on assets8.6%
Return on invested capital11.8%
Return on invested capital, 5-year average13.7%
Return on capital employed13.6%
Stock-based compensation / revenue1.3%

Financial position

At the end of fiscal 2025.

Cash and equivalents$9.13B
Total debt$55.44B
Net debt$46.31B
Current ratio1.14
Quick ratio1.01
Debt / equity6.40
Net debt / EBITDA3.25
Interest coverage3.30

Growth

Revenue, latest quarter on a year+8.5%
Revenue, twelve months on a year+8.2%
EPS, latest quarter on a year+19.4%
EPS, twelve months on a year+33.4%
Revenue, 5-year compound+7.6%
Revenue, 10-year compound+5.4%
Net income, 5-year compound+1.2%
Free cash flow, 5-year compound−3.9%
EPS, 5-year compound+2.9%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares542M
Shares outstanding, 5-year compound−1.7%
Net share repurchases$0.00
Dividends per share$9.66
Dividend payout66.5%

Taxes

For fiscal 2025, as filed.

Income tax expense$1.26B
Effective tax rate14.1%

AMGN in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.